{"schema_version":"secwatch.filing_event.v1","accession":"0001513162-23-000023","form_type":"8-K","ticker":"BMRA","cik":"0000073290","company_name":"BIOMERICA INC","filed_at":"2023-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.934652+00:00","generated_at":"2026-06-18T16:32:43.956927+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Biomerica appoints Gary Lu as CFO effective March 1, 2023","bullets":["Gary Lu, 42, previously Controller/VP Finance at Happy Money (Sep 2019-Feb 2023).","Lu receives $260,000 base salary and option for 75,000 shares vesting 25% annually over 4 years.","Steve Sloan steps down as interim CFO but remains advisor through Q3 FY2023 10-Q filing.","Lu is a CPA with a BA in Economics/Accounting from UCLA; began career at Ernst & Young."],"urls":{"canonical":"https://secwatch.observer/filing/0001513162-23-000023","json":"https://secwatch.observer/filing/0001513162-23-000023.json","markdown":"https://secwatch.observer/filing/0001513162-23-000023.md","text":"https://secwatch.observer/filing/0001513162-23-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/73290/000151316223000023/0001513162-23-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/73290/000151316223000023/bmra-20230301.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T16:32:43.956927+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6323505851","claim":"Gary Lu was appointed as Chief Financial Officer at BIOMERICA INC.","evidence_excerpt":"Effective March 1, 2023, the Board of Directors of Biomerica, Inc. (the “Company”) appointed Gary Lu as its Chief Financial Officer, principal financial officer and principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000151316223000023/0001513162-23-000023-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"b6f05ee936","claim":"Steve Sloan departed as interim Chief Financial Officer at BIOMERICA INC.","evidence_excerpt":"In connection with Mr. Lu’s appointment as Chief Financial Officer, Steve Sloan, the Company’s former Chief Financial Officer and current interim Chief Financial Officer, stepped down as interim Chief Financial Officer, effective as of March 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000151316223000023/0001513162-23-000023-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}